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Arraymethodologies have become powerful tools for
interrogation of glycan-protein interactions but have
critically lacked the ability to generate cell response
data. Here, we report the development of a slide-
based array method exemplified by measurement
of activation of fibroblast growth factor signaling by
heparin saccharides. Heparan sulfate-deficient
Swiss 3T3 cells were overlaid onto an aminosilane-
coated slide surface onto which heparin saccharides
had been spotted and immobilized. The cells were
transiently stimulatedwith FGF2 and immunofluores-
cence measured to assess downstream ERK1/2
phosphorylation. Activation of this signaling path-
way response was restricted to cells exposed to
heparin saccharides competent to activate FGF2
signaling. Differential activation of the overlaid cells
by different-sized heparin saccharides was demon-
strated by quantitativemeasurement of fluorescence
intensity. This ‘‘glycobioarray’’ platform has signifi-
cant potential as a generic tool for functional glyco-
mics screening.
INTRODUCTION
Glycomics is an emerging field that aims to develop large-scale
integrated systems approaches to study structure-function
relationships of glycans. A review of the current state of the art
in the field of glycomics reveals an emerging availability of
high-throughput methods for interrogating structure-function
relationships using glycan libraries (Otto et al., 2011). Microar-
rays have been the subject of considerable interest over recent
years, as a powerful tool in the post-genome era for exploring
gene expression and molecular interactions on a large scale.
More recently, DNA and RNAi transfection, and small molecule
screening, have been developed to monitor the responses
of living cells that are overlaid onto microarray surfaces
(Bailey et al., 2004; Lee et al., 2008; Wheeler et al., 2004). Micro-
arrays displaying glycans—‘‘glycoarrays’’—for interrogationChemistry & Biology 19,with protein probes, developed by ourselves and others, are
also proving critical for defining glycan-protein interactions,
including heparin/heparan sulfate (HS)-protein interactions
(Fukui et al., 2002; Blixt et al., 2004; Noti et al., 2006; Paulson
et al., 2006; Zhi et al., 2006; de Paz et al., 2007; Laurent et al.,
2008; Wakao et al., 2008; Zhi et al., 2008; Song et al., 2011a,
2011b). In relation to cell interactions, glycan arrays have been
applied to the assessment of adhesion of bacteria, viruses,
and mammalian cells to glycans (Nimrichter et al., 2004;
Dickinson et al., 2010; Sardzı´k et al., 2011; Song et al., 2011a,
2011b; Arndt et al., 2011). However, to the best of our knowl-
edge, their application to generate functional data on the conse-
quences of cell-glycan interactions in terms of cellular responses
of living cells (such as activation of intracellular signaling path-
ways) has not been demonstrated.
HS is a ubiquitous linear glycosaminoglycan that is found
attached to any of several families of core proteins to form
complex glycoproteins. It is diverse in its cellular and extracel-
lular distributions and is critical in a range of biological activities
from development to signaling regulation (Bernfield et al., 1999).
A highly sulfated version of HS, heparin, is used as a pharmaceu-
tical drug for its anticoagulative properties. The structural diver-
sity of HS within and between tissues is generated by the action
of a complex family of biosynthetic enzymes. Spatial and
temporal regulations of the expression and bioactivity of the
enzymes, as well as the fact that the reactions are not template
driven and do not go to completion, account for the diversity in
HS structure (Turnbull et al., 2001). These modifications occur
in a regulated fashion with certain modifications occurring in
discrete areas. Regions of modifications tend to cluster in highly
sulfated areas (S domains), whereas stretches on unmodified
disaccharides containing N-acetylated glucosamine residues
form NA domains (Turnbull and Gallagher, 1990; Turnbull et al.,
2001). One of the major challenges of the field is to analyze the
biological activity of the many different species of HS in order
to develop a detailed understanding of their structure-function
relationships (Powell et al., 2004).
Here, we describe a novel slide-based assay, which, to our
knowledge, provides for the first time (Figure 1) a functional gly-
coarray format. It relies on measurement of responses by fluo-
rescence detection of endogenous markers, and avoids reliance
on sophisticated microscopic equipment for image acquisition.
We demonstrate proof of concept and a key application by553–558, May 25, 2012 ª2012 Elsevier Ltd All rights reserved 553
Figure 1. A Slide Array Method for Assaying Functional Responses
of Cells to Immobilized Saccharides
Saccharides can be immobilized onto an aminosilane glass surface via
a Schiff’s base linkagewith their reducing ends, as shown in the inset. Reporter
cells are then overlaid onto the slide surface and cultured for a specified
period, followed by fixation and immunostaining to detected specific epitopes
using a microarray slide scanner.
See also Figure S1.
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prototypical activation of fibroblast growth factor (FGF) signaling
by heparin saccharides with differential activities. This assay
platform allows the simultaneous functional assessment of
different HS/heparin structures and should have broad utility
as a new glycomics tool.
RESULTS
Slide-Based Assay for FGF Signaling Responses
To demonstrate proof of concept of a slide-based assay, we
chose to study activation of FGF signaling by HS in sulfate-defi-
cient Swiss 3T3 cells. These have the advantages that they natu-
rally express only a single isoform of FGF receptor, FGF receptor
1 IIIc (FGFR1IIIc) (Pelech et al., 1986), and that the procedure for
the depletion of HS sulfation using chlorate is well characterized
(Rapraeger et al., 1994). Thus, responses to FGF can be directly
ascribed to exogenous addition of saccharides and signaling by
FGFR1IIIc. The efficacy of the chlorate-induced depletion of HS
sulfation in Swiss 3T3 cells grown on aminosilane-coated
surfaces was confirmed by immunofluorescence using an
anti-HS antibody that recognizes sulfated epitopes (see Supple-
mental Experimental Procedures and Figure S1A available
online). We chose to examine signaling responses to FGF2 via
phosphorylation of two important members of the mitogen-acti-
vated protein kinase (MAPK) family pathway: the extracellular
signal-regulated kinases 1 and 2 (ERK1/2) (Cano and Mahade-
van, 1995). Because ERK1/2 activation in Swiss 3T3 cells has
been shown to be dependent on cell adhesion (Pennington
et al., 2007), and can alter responses to growth factors (Sergeant
et al., 2000), we first determined whether adhesion of chlorate-
treated cells was similar on aminosilane slides and standard554 Chemistry & Biology 19, 553–558, May 25, 2012 ª2012 Elseviertissue culture glass substratum; immunofluorescence for b-actin
and vinculin confirmed that cell adhesion was similar on these
surfaces (Figure S1B).
Next, we examined a variety of spotting conditions to optimize
saccharide coupling via Schiff’s base formation (Yates et al.,
2003). Heparin 12-mer saccharides, which are known to activate
FGF signaling (Delehedde et al., 2000), were spotted in triplicate
in different solutions (500 nl each) onto an aminosilane surface
and coupled via a microwave-enhanced reaction (Powell et al.,
2009). Chlorate-treated cells were overlaid onto the slide and
following serum starvation were treated with FGF2 (10 ng/ml)
for 90 min. Cells were then fixed and stained for both total and
phosphorylated ERK1/2 (pERK1/2), using specific secondary
antibodies conjugated to different fluorophores, corresponding
to the two wavelengths detected by a microarray scanner
(535/557–592 nm and 635/650–690 nm) (see Experimental
Procedures). Fluorescence slide scanning demonstrated that
betaine produced spots with the most significantly increased
levels of fluorescence intensity for pERK1/2 (Figures 2A–2C,
S2A, and S2B), with no significant change in total ERK1/2
(Figures 2D, 2E, and S2C). A signal-to-noise ratio of 7:1 was
observed for pERK1/2 at 90 min (Figure 2C), indicative of
sustained activation of FGF signaling observed in previous
experiments in standard cell culture (Delehedde et al., 2000). In
contrast the other spotting conditions did not produce signifi-
cantly increased pERK1/2 (Figure S2B), and levels of total
ERK1/2 were unaltered by the different sugar-conjugation reac-
tion conditions (Figure S2C). Betaine is also well established for
improving spot homogeneity in microarrays (Diehl et al., 2001)
and was chosen for all further experiments.
Inhibition of ERK1/2 Activation in Slide-Based Assay
To confirm the specificity of the immunofluorescence pERK1/2
detection of FGF signaling, we employed the inhibitor
PD098059 that inhibits phosphorylation of pERK1/2 (Delehedde
et al., 2000) by binding to the inactive forms of MEK1 and pre-
venting activation by upstream activators such as c-Raf. A total
of 50 mM PD098059 effectively inhibited levels of DNA synthesis
in chlorate-treated Swiss 3T3 cells in standard culture condi-
tions, using western blotting to analyze phosphorylated and total
ERK protein levels (Figure S3A). Addition of the inhibitor reduced
the level of pERK1/2 down to negative control levels. No effect
was observed on phosphorylation with the addition of inhibitor
in the absence of FGF2 stimulation. Pretreatment with the inhib-
itor PD098059 prior to FGF2 and heparin 12-mer saccharide
stimulation was also associated with inhibition of DNA synthesis
levels (Figure S3B), a commonly used measure of cell prolifera-
tion. When MEK1 inhibitor was added to the medium of chlo-
rate-treated cells cultured on aminosilane slides prior to the
addition of FGF2, elevation of pERK1/2 in the presence of
heparin 12-mer saccharide was abolished (Figure S3C). Thus,
the immunofluorescence observed by slide scanning depends
specifically on phosphorylation of ERK1/2 induced by activation
of FGF signaling.
Measurement of Differential Activation of FGF Signaling
Wenext investigatedwhether the slide-based assay can be used
as a tool for screening the differential activities of saccharides,
using three size-defined heparin saccharides predominantlyLtd All rights reserved
Figure 2. Immobilized Heparin Oligosaccharides
Induce ERK1/2 Phosphorylation in HS-Deficient
Cells Responding to FGF2 in a Slide-Based Assay
(A) An aminosilane slide was spotted with a heparin 12-
mer saccharide or control (no saccharide) in betaine, and
overlaid with HS-deficient (chlorate-treated) Swiss 3T3
cells. After overnight adherence and 24 hr serum starva-
tion, the cells were stimulated with FGF2 for 90 min and
then fixed and stained for pERK1/2 using anti-p44/42
primary antibody and anti-mouse Alexa Fluor 555
secondary antibody (see Experimental Procedures).
(B) and (D) show individual triplicate spots immunostained
for pERK1/2 or total ERK1/2 protein, respectively.
(C) and (E) show fluorescence intensity of spot areas for
pERK1/2 and total ERK1and /2, respectively, measured
using a slide scanner (mean ± SD for triplicate spots from
a single slide). AU, arbitrary units.
See also Figure S2.
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units (for preparation details see Supplemental Experimental
Procedures and Figure S3D). These comprised two activating
heparin saccharides (12- and 18-mer) and a nonactivating
counterpart (2-mer), previously tested in cell culture assays
(Delehedde et al., 2000; Walker et al., 1994). Saccharides
were spotted and responses to FGF2 measured as described
above for Figure 2. Analysis of the array demonstrated increased
immunofluorescence for pERK1/2 for the heparin 12- and
18-mer spots (Figures 3A and 3B). In the case of the heparin
2-mer and negative control, there was no increase in fluores-
cence intensity when compared to the surrounding areas.
Total ERK1/2 was comparable across the different conditions
(Figure 3C). The activity of these saccharides was also
consistent with DNA synthesis assays with chlorate-treated
Swiss 3T3 cells in standard cell culture (Figure S3E). In chlo-
rate-treated cells FGF2 alone or in the presence of disaccharides
did not stimulate DNA synthesis and only elicited an early
transient dual phosphorylation of p42/44 MAPK, whereas
FGF2 in the presence of tetrasaccharides and longer oligosac-
charides was able to restore DNA synthesis and enable the
sustained dual phosphorylation of p42/44MAPK (Delehedde
et al., 2000).Chemistry & Biology 19, 553–558, May 25Quantitative analysis of spot intensity
demonstrated statistically significant activation
of signaling (measured by elevated pERK1/2)
by both 12- and 18-mer heparin saccharides,
whereas the 2-mer was not significantly
different from the negative control (Fig-
ure 3D, and corresponding immunofluores-
cence microscopy images in Figure S3F),
whereas total ERK1/2 levels were not signifi-
cantly altered (Figure 3E). These data are in
agreement with data from standard cell culture
(Figure S3E) and previous literature data
(Delehedde et al., 2002). Differential activation
was also evident because a statistically signifi-
cant higher level of ERK phosphorylation to
produce pERK1/2 was noted for the 18-mer
compared to the 12-mer saccharide (Figure 3D;p = 0.04). Differential cell responses to spotting concentration
were observed to be dose dependent in this glycobioarray
format (Supplemental Experimental Procedures; Figure S3G).
This is consistent with previous cell culture literature, and
suggests as expected a dependence on the amount of glycan
immobilized; the latter varies with spotting concentration, as
noted previously for measurement of protein binding in standard
glycoarrays (Zhi et al., 2006; Noti et al., 2006; de Paz et al., 2007;
Zhi et al., 2008; Powell et al., 2009). Overall, these data provide
evidence that this technique is sufficiently sensitive to measure
quantitative differences in cell responses to immobilized heparin
glycans in terms of FGF2 signaling activation via detection of the
levels of pERK1/2 in the MAPK pathway.
DISCUSSION
Here, we have demonstrated a method for measuring the
responses of living cells overlaid on immobilized glycans in
a slide-based array format (Figure 1). The activation of FGF2
by the heparin/HS family of glycans provides a prototypic system
for demonstrating this assay. HS-deficient (chlorate-treated)
Swiss 3T3 cells were overlaid onto aminosilane-coated slide
surfaces onto which heparin saccharides had previously been, 2012 ª2012 Elsevier Ltd All rights reserved 555
Figure 3. Slide-Based Assay of FGF Signaling Acti-
vation by Size-Defined Heparin Oligosaccharides
(A) HS-deficient (chlorate-treated) cells were seeded
onto an aminosilane slide spotted with various saccha-
rides in betaine and treated as described in Figure 2 to
measure FGF2 signaling, and array was immunostained
for pERK1/2.
(B) and (C) show individual triplicate spots immunostained
for pERK1/2 or total ERK1/2 protein, respectively.
(D) and (E) show fluorescence intensity of spot areas for
pERK1/2 and total ERK1/2, respectively, measured using
a slide scanner (mean ± SD for triplicate spots from a single
slide). Statistical analysis was performed using the two-
tailed t test assuming equal variance: **p% 0.005 and *p%
0.05 (n = 3). In (D) the 2-mer heparin saccharide and nega-
tive control are not significantly different. AU, arbitrary units.
See also Figure S3.
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with FGF2 and immunofluorescence measured to assess the
level of ERK1/2 phosphorylation. Activation of this signaling
pathway response was restricted to cells exposed to heparin
saccharides competent to activate FGF2 signaling. Differential
activation of the overlaid cells by different-sized heparin saccha-
rides was demonstrated by quantitative measurements of fluo-
rescence intensity, andwas consistent with previously published
data in traditional cell assays.
This slide-based functional screening assay can be used to
simultaneously screen different populations of heparin/HS
saccharide structures. The screening tool obtains quantitative
data from facile fluorescence intensity measurements, produc-
ing clear differentiation of different species of HS/heparin. The
immunostaining protocol used here for analyzing the activation
of pERK can be readily adapted by changing the choice of anti-
body used in the protocol; thus, a range of different cell markers
can be assessed to study different cell processes such as cell
differentiation and cell growth.
Although arraymethods have been described employing living
cells for RNAi transfection and small molecule responses (Bailey
et al., 2004; Erfle et al., 2007; Wheeler et al., 2004, 2005), and556 Chemistry & Biology 19, 553–558, May 25, 2012 ª2012 Elsevier Ltd All rights resemeasuring binding of bacteria, viruses, and
mammalian cells to immobilized glycans (Nim-
richter et al., 2004; Dickinson et al., 2010;
Sardzı´k et al., 2011; Song et al., 2011a, 2011b;
Arndt et al., 2011), to our knowledge, this is
the first demonstration of a slide-based tech-
nology for analysis of cellular responses to
glycans. Current in vitro functional assays using
cell biology approaches often require high cell
numbers or larger amounts of reagents that
are not always available, especially in the case
of saccharides. Therefore, the development of
slide-based functional screening assays may
allow the screening and differentiation of
different and larger populations of saccharide
structures. The platform we describe here has
significant potential for further development
as a generic tool for functional glycomics
screening of a wide range of glycans. The meth-odology is easily applicable to a standard laboratory setting
because images are acquired using only a DNA microarray
scanner. It has a number of advantages, including rapidity, provi-
sion of miniaturization (and thus low reagent usage), and also
significant potential for development as a high-throughput tool.
SIGNIFICANCE
The development of array-based assay technologies is
a much-needed method for assessing glycan function,
especially in the case of the heparan sulfate (HS) family.
This methodology now has the potential to be extended to
study natural HS saccharide libraries, the production of
which has recently been described by Powell et al. (2010),
and also HS saccharides produced by synthetic chemistry
(Noti et al., 2006; de Paz et al., 2007; Arungundram et al.,
2009). Furthermore, such saccharides can be robotically
spotted into array formats (Zhi et al., 2006, 2008; Noti et al.,
2006; de Paz et al., 2007; Powell et al., 2009) that would allow
the large-scale simultaneous analysis of different structures
for the first time. Such studies could directly address the
structure-function relationships of HS saccharides atrved
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tool for glycan analysis.
EXPERIMENTAL PROCEDURES
Cell Culture and Depletion of Sulfation from Swiss 3T3 Cells
Swiss 3T3 cells (ATCC CCL-92) were grown in a medium depleted of sulfate
and containing sodium chlorate to inhibit the sulfation of endogenous HS
proteoglycans. The sulfate-free culture was prepared without sodium chloride
or cystine using individual ingredients devoid of sulfate also known as the
sulfate-free medium. A detailed explanation of reagents and methods is given
in Rapraeger et al. (1994). Different conditions were used as controls to block
or restore the inhibition of HS sulfation, including pretreatment medium A and
B, as previously described by Rapraeger et al. (1994).
Immobilization of Oligosaccharides onto Aminosilane Surfaces
The preparation of size-defined heparin oligosaccharides using heparinase
digestion and gel filtration chromatography (Powell et al., 2010) is described
in Supplemental Experimental Procedures and Figure S3. Freeze-dried oligo-
saccharides (at final concentration 1 mM) were dissolved in betaine (Sigma-
Aldrich), betaine and formamide (Fluka), water, or formamide. Betaine was
used at 1.5 M. Spots were grouped in an appropriate area of the aminosilane
glass slide, which was marked using a diamond-tipped pen. Sugars were
spotted manually by pipette in triplicate (500 nl per spot), and the slide was
microwaved and prepared as previously described by Powell et al. (2009).
Molarity was used instead of weight in order to provide an equal comparison
between different-sized heparin saccharides.
Optimization of Spotting Conditions
Cells were chlorate treated as previously explained. Cells were washed with
PBS, split using 0.5% TE, and allowed to adhere for 24 hr onto the slide in
a 10 cm sterile tissue culture dish (Corning). Cells were thenwashed and serum
starved for 24 hr in pretreatment media A containing 0.1% (w/v) dialyzed BSA.
Cells were incubated in pretreatment media A for 24 hr at 37C. Cells were
stimulated with 10 ng/ml FGF2 for 90 min at 37C and 5% CO2. After 90 min
the cells were washedwith ice-cold PBS and fixedwith 4%paraformaldehyde.
The cells were washed with PBS, blocked with 5% BSA (w/v) in PBSTX.
Anti-phospho-MAPK IgG antibody primary antibody phosphorylated-p44/42
MAPK (ERK1/2) (Thr202/Tyr204) antibody (Cell Signaling) primary antibody
was added in 3%BSA in PBSTX and used at 1/200 dilution with overnight incu-
bation at 4C. The slide was washed three times in PBS and the secondary
Alexa Fluor 555 anti-mouse IgG Fab fragment antibody (excitation 555 and
emission 565). Total ERK was measured using p44/42 MAPK (ERK1/2)
antibody (Cell Signaling), and anti-rabbit Alexa Fluor 635 was used as a
secondary antibody. The slide was washed in PBS, allowed to dry, and stored
in a fluorescence case until scanned. Inhibitors of MEK1 (in solution PD098059
[Calbiochem]) were added as detailed in the figure legends.
Microarray Scanning
Scanned images were obtained using an AXON GenePix 4000A (Axon Instru-
ments). Axon voltage and signal intensities were set to 100%, respectively, of
635 and 535 nm wavelength. Mean signal intensities were calculated for the
total signal in the spot area. ImageJ software was used for image acquisition
and analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.chembiol.2012.03.011.
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